Niko Sahlberg

774 total citations
8 papers, 631 citations indexed

About

Niko Sahlberg is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Niko Sahlberg has authored 8 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Niko Sahlberg's work include HER2/EGFR in Cancer Research (2 papers), Peptidase Inhibition and Analysis (1 paper) and Yeasts and Rust Fungi Studies (1 paper). Niko Sahlberg is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Peptidase Inhibition and Analysis (1 paper) and Yeasts and Rust Fungi Studies (1 paper). Niko Sahlberg collaborates with scholars based in Finland, Italy and Norway. Niko Sahlberg's co-authors include Merja Perälä, Lea Sistonen, Johanna K. Ahlskog, Andrey Mikhailov, Jorma J. Palvimo, Carina I. Holmberg, Lila Pirkkala, Ville Hietakangas, Olli Kallioniemi and Kirsi Hellström and has published in prestigious journals such as Molecular and Cellular Biology, Oncogene and European Journal of Cancer.

In The Last Decade

Niko Sahlberg

8 papers receiving 618 citations

Peers

Niko Sahlberg

MB

CR

ONCOL

CB

IMMUN

Sabrina Fritah Luxembourg

XiaoZhe Wang United States

Sonnet J.H. Arlander United States

Johanna K. Ahlskog Finland

Olesya V. Bukach Russia

Charalampos Lazaris United States

Ilaria Chiodi Italy

Yvonne Nymalm Finland

D.B. Zimonjic United States

Heike Arlt United States

Sabrina Fritah Luxembourg

Niko Sahlberg

742 ×1.4

MB

277 ×1.4

CR

149 ×1.2

ONCOL

94 ×0.9

CB

104 ×2.0

IMMUN

Citations per year, relative to Niko Sahlberg Niko Sahlberg (= 1×) peers Sabrina Fritah

Countries citing papers authored by Niko Sahlberg

Since Specialization

Citations

This map shows the geographic impact of Niko Sahlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niko Sahlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niko Sahlberg more than expected).

Fields of papers citing papers by Niko Sahlberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niko Sahlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niko Sahlberg. The network helps show where Niko Sahlberg may publish in the future.

Co-authorship network of co-authors of Niko Sahlberg

This figure shows the co-authorship network connecting the top 25 collaborators of Niko Sahlberg. A scholar is included among the top collaborators of Niko Sahlberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niko Sahlberg. Niko Sahlberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Perälä, Merja, Vidal Fey, Niko Sahlberg, et al.. (2016). A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability. Oncotarget. 7(19). 28510–28522. 12 indexed citations

2.

Sahlberg, Kristine Kleivi, Vesa Hongisto, Henrik Edgren, et al.. (2012). The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells. Molecular Oncology. 7(3). 392–401. 69 indexed citations

3.

Hongisto, Vesa, Kristine Kleivi Sahlberg, Henrik Edgren, et al.. (2012). 338 The HER2 Amplicon Includes Several Genes Required for the Growth and Survival of HER2 Positive Breast Cancer Cells. European Journal of Cancer. 48. S82–S83. 1 indexed citations

4.

Mattila, Elina, Niko Sahlberg, Pekka Kohonen, et al.. (2010). Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase. BMC Cancer. 10(1). 7–7. 36 indexed citations

5.

Härmä, Harri, Ilkka Hemmilä, Niko Sahlberg, et al.. (2009). A New Simple Cell-Based Homogeneous Time-Resolved Fluorescence QRET Technique for Receptor-Ligand Interaction Screening. SLAS DISCOVERY. 14(8). 936–943. 32 indexed citations

6.

Leivonen, Suvi‐Katri, Riikka Mäkelä, Päivi Östling, et al.. (2009). Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene. 28(44). 3926–3936. 202 indexed citations

7.

Hietakangas, Ville, Johanna K. Ahlskog, Niko Sahlberg, et al.. (2003). Phosphorylation of Serine 303 Is a Prerequisite for the Stress-Inducible SUMO Modification of Heat Shock Factor 1. Molecular and Cellular Biology. 23(8). 2953–2968. 254 indexed citations

8.

Issakainen, Jouni, et al.. (2003). Relationships ofScopulariopsisbased on LSU rDNA sequences. Medical Mycology. 41(1). 31–42. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact